首页> 外文期刊>Journal of bronchology & interventional pulmonology >Transmission of Multidrug-resistant Tuberculosis Confirmed by Endobronchial Ultrasound Biopsy of a Mediastinal Lymph Node and DNA Fingerprinting Analysis
【24h】

Transmission of Multidrug-resistant Tuberculosis Confirmed by Endobronchial Ultrasound Biopsy of a Mediastinal Lymph Node and DNA Fingerprinting Analysis

机译:纵隔淋巴结的支气管内超声检查证实多药耐药性结核病的传播及DNA指纹图谱分析

获取原文
获取原文并翻译 | 示例
       

摘要

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was recently introduced for sampling of mediastinal masses and nodes, for staging of lung cancer, and for diagnosing other benign diseases including tuberculosis (TB). However, EBUS-TBNA has not been used to date to confirm the presence of multidrug-resistant TB (MDR-TB). We here describe the diagnosis of MDR-TB of a mediastinal lymph node by EBUS biopsy. MDR-TB had been transmitted to our patient from her son who had pulmonary TB, and the diagnosis of MDR-TB was confirmed by a restriction fragment length polymorphism analysis of the IS6110 segment of Mycobacterium tuberculosis isolates. Our findings highlight the use of EBUS-TBNA in diagnosing TB, including MDR-TB, and malignancies, in a TB-endemic area.
机译:最近引入了支气管内超声引导的经支气管穿刺针抽吸术(EBUS-TBNA),用于纵隔肿块和淋巴结采样,肺癌分期以及诊断包括肺结核(TB)在内的其他良性疾病。但是,迄今为止,尚未使用EBUS-TBNA确认是否存在耐多药结核病(MDR-TB)。我们在这里描述通过EBUS活检对纵隔淋巴结MDR-TB的诊断。 MDR-TB已从其患有肺结核的儿子传染给我们的患者,并且通过结核分枝杆菌分离株IS6110片段的限制性片段长度多态性分析证实了MDR-TB的诊断。我们的研究结果突显了EBUS-TBNA在结核病流行地区诊断结核病(包括耐多药结核病和恶性肿瘤)中的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号